Stock listing
NASDAQ:VCEL Vericel Corporation Stock
Home listing (NASDAQ) of Vericel Corporation
Follow Vericel Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:VCEL
$57.52 USD -1.13 (-1.9%)
Close on Nov 20, 2026
- Day range
- $57.33 – $59.49 USDNov 20, 2026
- Volume
- 582,315 sharesNov 20, 2026
- Market cap
- $2.94B USDAt the close on Nov 20, 2026 · price × 51.03M shares outstanding
- 52-week range
- $28.95 – $59.75 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $30.08M USDMedian day 567,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VCEL · Home | $57.52 USD | -1.13 (-1.9%) | 582,315 | $58.11 | $59.49 | $57.33 | $58.65 | Close on Nov 20, 2026 |
| Frankfurt:ATQP | €53.50 EUR | 0.00 (0.0%) | — | €52.50 | €53.50 | €52.50 | €53.50 | Close on Nov 20, 2026 |
| Munich:ATQP | €53.00 EUR | -0.50 (-0.9%) | — | €53.00 | €53.00 | €53.00 | €53.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:VCEL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $57.52 | -1.13 | -1.9% | $58.11 | $59.49 | $57.33 | 582,315 | |
| $58.65 | +0.77 | +1.3% | $57.88 | $59.57 | $57.75 | 832,429 | |
| $57.88 | +0.40 | +0.7% | $57.48 | $58.68 | $57.32 | 555,302 | |
| $57.48 | +0.52 | +0.9% | $56.85 | $58.63 | $56.71 | 972,843 | |
| $56.96 | -0.46 | -0.8% | $57.66 | $58.42 | $56.86 | 698,340 | |
| $57.42 | -2.03 | -3.4% | $59.50 | $59.50 | $56.92 | 826,521 | |
| $59.45 | +0.42 | +0.7% | $58.50 | $59.75 | $57.85 | 809,203 | |
| $59.03 | +0.64 | +1.1% | $58.39 | $59.72 | $57.83 | 1,331,156 | |
| $58.39 | +3.77 | +6.9% | $56.00 | $59.48 | $55.60 | 1,750,519 | |
| $54.62 | +2.84 | +5.5% | $51.79 | $54.64 | $50.76 | 1,612,301 | |
| $51.78 | +6.30 | +13.9% | $50.54 | $55.60 | $49.00 | 2,677,363 | |
| $45.48 | +4.39 | +10.7% | $42.07 | $45.98 | $42.07 | 1,742,273 | |
| $41.09 | +0.58 | +1.4% | $40.52 | $41.50 | $40.36 | 635,179 | |
| $40.51 | +0.25 | +0.6% | $40.29 | $40.88 | $39.44 | 684,368 | |
| $40.26 | -2.65 | -6.2% | $43.02 | $43.02 | $40.01 | 598,732 | |
| $42.91 | +1.82 | +4.4% | $41.99 | $43.05 | $41.48 | 544,830 | |
| $41.09 | -2.18 | -5.0% | $43.05 | $43.50 | $40.59 | 680,183 | |
| $43.27 | +0.23 | +0.5% | $43.04 | $43.74 | $42.65 | 558,356 | |
| $43.04 | +0.51 | +1.2% | $42.73 | $43.83 | $42.30 | 634,752 | |
| $42.53 | -0.44 | -1.0% | $42.99 | $43.00 | $41.75 | 494,700 | |
| $42.97 | +2.03 | +5.0% | $41.21 | $43.01 | $40.02 | 604,900 | |
| $40.94 | +0.36 | +0.9% | $40.00 | $41.04 | $40.00 | 432,000 | |
| $40.58 | +0.21 | +0.5% | $40.81 | $41.03 | $39.97 | 475,300 | |
| $40.37 | +0.24 | +0.6% | $40.36 | $40.95 | $40.04 | 334,200 | |
| $40.13 | -0.89 | -2.2% | $41.07 | $41.55 | $39.71 | 737,100 | |
| $41.02 | +0.77 | +1.9% | $40.77 | $41.60 | $40.26 | 601,200 | |
| $40.25 | -0.05 | -0.1% | $39.90 | $40.31 | $39.60 | 384,500 | |
| $40.30 | -0.32 | -0.8% | $40.62 | $40.77 | $39.99 | 511,700 | |
| $40.62 | +0.52 | +1.3% | $40.30 | $40.81 | $39.00 | 432,900 | |
| $40.10 | +0.05 | +0.1% | $39.83 | $41.13 | $39.78 | 506,900 | |
| $40.05 | -0.69 | -1.7% | $40.53 | $40.94 | $39.81 | 749,100 | |
| $40.74 | +0.69 | +1.7% | $39.67 | $41.40 | $39.50 | 647,000 | |
| $40.05 | -1.02 | -2.5% | $41.38 | $41.45 | $39.65 | 669,000 | |
| $41.07 | +0.92 | +2.3% | $40.13 | $41.17 | $39.93 | 648,600 | |
| $40.15 | +0.71 | +1.8% | $40.01 | $40.40 | $39.37 | 479,200 | |
| $39.44 | -0.70 | -1.7% | $40.27 | $40.72 | $39.29 | 497,300 | |
| $40.14 | -0.47 | -1.2% | $40.79 | $41.08 | $39.82 | 585,400 | |
| $40.61 | +0.37 | +0.9% | $40.27 | $40.83 | $39.93 | 526,900 | |
| $40.24 | +0.53 | +1.3% | $39.78 | $41.05 | $39.65 | 643,100 | |
| $39.71 | +0.41 | +1.0% | $39.30 | $39.80 | $38.74 | 359,300 | |
| $39.30 | +0.51 | +1.3% | $38.86 | $39.40 | $38.39 | 352,000 | |
| $38.79 | -1.43 | -3.6% | $39.95 | $40.10 | $38.21 | 434,000 | |
| $40.22 | +0.67 | +1.7% | $40.00 | $40.42 | $39.55 | 547,000 | |
| $39.55 | -0.47 | -1.2% | $40.08 | $40.29 | $39.05 | 402,200 | |
| $40.02 | -0.01 | 0.0% | $39.80 | $40.21 | $39.57 | 1,126,500 | |
| $40.03 | -0.18 | -0.4% | $40.62 | $40.62 | $39.06 | 536,400 | |
| $40.21 | +0.49 | +1.2% | $39.73 | $40.87 | $39.73 | 490,500 | |
| $39.72 | +0.12 | +0.3% | $39.39 | $40.15 | $38.55 | 654,800 | |
| $39.60 | +1.26 | +3.3% | $38.58 | $39.70 | $38.20 | 629,400 | |
| $38.34 | +0.47 | +1.2% | $38.39 | $38.95 | $37.35 | 503,500 | |
| $37.87 | -1.12 | -2.9% | $38.56 | $38.82 | $37.67 | 340,200 | |
| $38.99 | -0.09 | -0.2% | $38.72 | $39.19 | $38.53 | 366,500 | |
| $39.08 | -1.11 | -2.8% | $39.69 | $39.72 | $38.74 | 410,300 | |
| $40.19 | -0.28 | -0.7% | $40.04 | $40.57 | $39.85 | 312,900 | |
| $40.47 | -0.42 | -1.0% | $41.30 | $41.30 | $40.09 | 301,300 | |
| $40.89 | +0.39 | +1.0% | $40.49 | $41.49 | $40.35 | 395,500 | |
| $40.50 | +0.60 | +1.5% | $39.87 | $41.44 | $39.66 | 651,100 | |
| $39.90 | -1.05 | -2.6% | $40.48 | $40.88 | $39.34 | 636,300 | |
| $40.95 | -0.23 | -0.6% | $41.18 | $41.47 | $40.51 | 491,200 | |
| $41.18 | -1.26 | -3.0% | $42.39 | $42.65 | $41.16 | 533,500 | |
| $42.44 | -0.78 | -1.8% | $43.22 | $43.22 | $42.33 | 313,600 | |
| $43.22 | +0.92 | +2.2% | $42.95 | $43.25 | $42.53 | 465,742 | |
| $42.30 | -0.38 | -0.9% | $42.68 | $43.34 | $41.95 | 812,270 | |
| $42.68 | +0.57 | +1.4% | $42.36 | $42.85 | $41.76 | 647,100 | |
| $42.11 | -1.46 | -3.4% | $42.83 | $43.48 | $41.68 | 567,700 |
Splits
2 splits since 2010 · NASDAQ:VCEL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation | |
| 1-for-8 | Consolidation |
- Ticker
- NASDAQ:VCEL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 13, 2026
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
Latest earnings call · Nov 5, 2026
Vericel (NASDAQ:VCEL) Q3 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 25 slides
Latest news
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
Nov 13, 2026
Closed $56.96 (-0.8%) on Nov 13, 2026
Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
Nov 5, 2026
Closed $51.78 (+13.9%) on Nov 5, 2026
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 22, 2026
Closed $42.97 (+5.0%) on Oct 22, 2026
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
Sep 8, 2026
Closed $39.08 (-2.8%) on Sep 8, 2026
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
Jul 30, 2026
Closed $47.61 (+2.1%) on Jul 30, 2026
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
Jul 16, 2026
Closed $47.81 (+2.3%) on Jul 16, 2026
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Jun 9, 2026
Closed $37.03 (+3.5%) on Jun 9, 2026
Carticel Sm Service (Vericel) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
May 7, 2026
Closed $35.13 (-4.5%) on May 7, 2026
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
Apr 23, 2026
Closed $34.40 (+0.1%) on Apr 23, 2026
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
Apr 2, 2026
Closed $34.14 (+4.9%) on Apr 2, 2026
Vericel Corporation on 6ix
- News releases
- 15 in the last 12 months · 138 in all · newest Nov 13, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Nov 5, 2026
- Decks
- 40 decks · latest November 2026
Where Vericel Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VCEL · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A12FU4 | LS Exchange | Germany | EUR |
| gettex:ATQP | gettex | Germany | EUR |
| Lang & Schwarz:A12FU4 | Lang & Schwarz | Germany | EUR |
| Dusseldorf:ATQP | Dusseldorf | Germany | EUR |
| Frankfurt:ATQP | Frankfurt | Germany | EUR |
| Munich:ATQP | Munich | Germany | EUR |
| Stuttgart:ATQP | Stuttgart | Germany | EUR |
| Tradegate:ATQP | Tradegate | Germany | EUR |
| BOATS:VCEL | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.86B USD
- P/E
- 88.1×
- EV/sales
- 8.8×
- EV/EBITDA
- 70.3×
- Price/book
- 7.6×
- Gross margin
- 74.5%
- Operating margin
- 8.3%
- Net margin
- 10.3%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 0.49
Forecasts
7 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 65.43 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.75 · 5 analysts
- Revenue, year to Dec 2026
- 345.3M · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Dominick Colangelo | President and Chief Executive Officer |
| Michael Banffy | CEO |
| Joseph A. Mara | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Robert L. Zerbe | Chairman of the Board |
| Alan L. Rubino | Director |
| Heidi Hagen | Director |
| Kevin McLaughlin | Director |
| Lisa Wright | Director |
| Paul Wotton | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Vericel (NASDAQ:VCEL) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q1 2026 Earnings Call | Thu, May 07, 2026 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q2 2025 Earnings Call | Thu, Jul 31, 2025 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q1 2025 Earnings Call | Thu, May 08, 2025 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 8:30 AM ET | Replay |
| Vericel (NASDAQ:VCEL) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 8:30 AM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +13.8% |
| Q2 2026 | Jul 30, 2026 · Before open | +2.1% |
| Q1 2026 | May 7, 2026 · Before open | −4.5% |
| Q4 2025 | Feb 26, 2026 | −3.8% |
| Q3 2025 | Nov 6, 2025 · Before open | +4.2% |
| Q2 2025 | Jul 31, 2025 · Before open | −14.1% |
| Q1 2025 | May 8, 2025 · Before open | +3.5% |
| Q4 2024 | Feb 26, 2025 · Before open | +0.6% |
| Q3 2024 | Nov 7, 2024 · Before open | +4.1% |
| Q2 2024 | Aug 1, 2024 · Before open | −5.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 8, 2024 · Before open | −3.7% |
| Q4 2023 | Feb 29, 2024 · Before open | −4.4% |
| Q3 2023 | Nov 8, 2023 · Before open | −3.4% |
| Q2 2023 | Aug 2, 2023 · Before open | −1.4% |
| Q1 2023 | May 10, 2023 · Before open | +4.1% |
| Q4 2022 | Feb 23, 2023 · Before open | +7.3% |
| Q3 2022 | Nov 9, 2022 · Before open | −23.4% |
| Q2 2022 | Aug 3, 2022 · Before open | −0.3% |
| Q1 2022 | May 4, 2022 · Before open | −1.0% |
| Q4 2021 | Feb 24, 2022 · Before open | +20.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 25 slides | November 2026 |
| Investor Presentation (August 2026) | Investor deck | 25 slides | August 2026 |
| Q1 2026 Earnings Presentation | Earnings | 10 slides | May 7, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 8 slides | Feb 26, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 6 slides | Nov 6, 2025 |
| Investor Presentation (November 2025) | Investor deck | 25 slides | November 2025 |
| Q2 2025 Earnings Presentation | Earnings | 7 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 8 slides | May 8, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 12 slides | Feb 27, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 25 slides | Jan 14, 2025 |
All 40 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 276.3M | 237.2M | 197.5M | 164.4M | 156.2M | 124.2M | 117.8M | 90.9M | 63.9M | 54.4M |
| Cost of revenue | 70.7M | 65.1M | 61.9M | 54.6M | 50.2M | 40.0M | 37.6M | 32.2M | 30.4M | 28.3M |
| Gross profit | 205.6M | 172.1M | 135.6M | 109.8M | 106.0M | 84.2M | 80.3M | 58.7M | 33.6M | 26.1M |
| Research and development | 27.6M | 24.8M | 21.0M | 19.9M | 16.3M | 13.0M | 30.4M | 13.6M | 12.9M | 15.3M |
| Selling, general and administrative | 167.0M | 142.8M | 121.0M | 106.9M | 97.6M | 68.8M | 61.1M | 49.0M | 35.6M | 27.4M |
| Operating income | 11.0M | 4.52M | -6.46M | -17.1M | -7.85M | 2.37M | -11.3M | -3.91M | -15.0M | -19.2M |
| Depreciation and amortization | 11.5M | 5.50M | 4.63M | 3.98M | 2.96M | 2.38M | 1.70M | 1.43M | 1.61M | 1.89M |
| EBITDA | 22.6M | 10.0M | -1.83M | -13.1M | -4.89M | 4.75M | -9.55M | -2.48M | -13.4M | -17.4M |
| Interest expense | 630.0K | 614.0K | 600.0K | 366.0K | 4.00K | 6.00K | 8.00K | 31.0K | 92.0K | 15.0K |
| Income before tax | 17.4M | 10.5M | -2.37M | -16.0M | -7.58M | 3.04M | -9.66M | -8.14M | -17.3M | -19.6M |
| Income tax | 859.0K | 148.0K | 814.0K | 721.0K | -111.0K | 180.0K | 0 | 0 | 0 | 0 |
| Net income | 16.5M | 10.4M | -3.18M | -16.7M | -7.47M | 2.86M | -9.66M | -8.14M | -17.3M | -19.6M |
| Earnings per share, basic | 0.33 | 0.21 | -0.07 | -0.35 | -0.16 | 0.06 | -0.22 | -0.20 | -0.52 | -1.18 |
| Earnings per share, diluted | 0.32 | 0.20 | -0.07 | -0.35 | -0.16 | 0.06 | -0.22 | -0.20 | -0.52 | -1.18 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 100.1M | 74.5M | 69.1M | 51.1M | 68.3M | 33.6M | 26.9M | 18.3M | 26.9M | 23.0M |
| Short-term investments | 37.4M | 41.7M | 40.5M | 68.5M | 35.1M | 42.2M | 42.8M | 64.6M | 0 | 0 |
| Receivables | 84.6M | 61.4M | 58.4M | 46.5M | 37.4M | 34.5M | 32.2M | 23.5M | 18.3M | 17.1M |
| Inventory | 17.6M | 17.4M | 13.1M | 16.0M | 13.4M | 9.36M | 6.82M | 3.56M | 3.79M | 3.49M |
| Current assets | 247.4M | 212.8M | 205.6M | 186.9M | 158.5M | 123.6M | 111.7M | 112.8M | 50.5M | 44.7M |
| Property, plant and equipment | 57.4M | 59.0M | 57.7M | 32.2M | 5.91M | 4.07M | 3.88M | |||
| Goodwill | 0 | 0 | ||||||||
| Total assets | 488.0M | 432.7M | 353.7M | 273.0M | 243.7M | 205.6M | 153.2M | 118.7M | 54.6M | 48.6M |
| Accounts payable | 15.8M | 23.8M | 22.3M | 16.9M | 9.02M | 6.75M | 6.34M | 7.11M | 5.55M | 6.54M |
| Current liabilities | 49.1M | 50.3M | 45.7M | 37.5M | 26.1M | 22.5M | 19.8M | 14.8M | 13.1M | 12.9M |
| Long-term debt | 16.9M | 9.32M | ||||||||
| Total debt | 98.3M | 98.8M | 88.0M | 47.6M | 50.2M | 53.3M | 27.9M | 16.9M | 9.32M | |
| Total liabilities | 133.3M | 140.8M | 127.7M | 80.7M | 73.2M | 71.3M | 42.1M | 16.5M | 32.0M | 23.9M |
| Shareholders' equity | 354.6M | 292.0M | 226.0M | 192.3M | 170.5M | 134.3M | 111.1M | 102.2M | 22.5M | 24.7M |
| Shares outstanding | 50.6M | 49.6M | 47.8M | 47.3M | 46.9M | 45.8M | 44.9M | 43.6M | 35.9M | 31.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 51.9M | 58.2M | 35.3M | 17.7M | 29.0M | 17.6M | -7.18M | -412.0K | -13.2M | -19.9M |
| Capital spending | -27.2M | -64.0M | -20.0M | -7.60M | -7.92M | -2.63M | -2.62M | -2.68M | -1.51M | -1.42M |
| Free cash flow | 24.7M | -5.81M | 15.3M | 10.1M | 21.1M | 14.9M | -9.80M | -3.09M | -14.7M | -21.3M |
| Cash from investing | -43.9M | -79.0M | -3.13M | -36.2M | -3.50M | -17.2M | 10.6M | -67.0M | -1.51M | -1.42M |
| Cash from financing | 7.07M | 19.1M | 3.62M | 1.04M | 9.17M | 6.44M | 5.26M | 58.9M | 18.6M | 29.7M |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 3.65M | 11.2M | 6.63M | 5.29M | 77.1M | 12.4M | 19.5M | |||
| Change in cash | 15.0M | -1.82M | 35.8M | -17.5M | 34.7M | 6.85M | 8.69M | -8.58M | 3.88M | 8.40M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 9, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 9, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 9, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144/A · Notice of proposed sale, amended | Nov 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Nov 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 31, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 30, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 26, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 26, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 18, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 8-K · Current report | May 18, 2026 | Current report | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 13, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| 144 · Notice of proposed sale | May 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 8-K · Current report | May 1, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 2, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 1, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 27, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 23, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Mar 19, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 19, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Mar 19, 2026 | Annual report | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 11, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 13, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 7, 2026 | Other filings | SEC |
| 4 · Change in ownership | Dec 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 10, 2025 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Nov 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 31, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Results | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 30, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | May 15, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 14, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 9, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 8, 2025 | Offer document | SEC |
| S-8 · Registration statement for employee plans | May 8, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| 144 · Notice of proposed sale | May 7, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 8-K · Current report | May 2, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 30, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 14, 2025 | Current report | SEC |
| 4 · Change in ownership | Apr 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 9, 2025 | Other filings | SEC |
| DEFA14A · Additional proxy material | Mar 20, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 20, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Mar 20, 2025 | Annual report | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 13, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 25, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 20, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | Feb 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 19, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2025 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2025 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2025 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 11, 2025 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Vericel Corporation’s releases · as of Oct 29, 2026
- Common shares
- 51,029,770
- Fully diluted
- 51,029,770
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 51,029,770 | Oct 29, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 29, 2026 | 51,029,770 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Steven C Gilman Other companies: Akebia Therapeutics, Inc. (Director · Since at least Dec 12, 2018); Scynexis, Inc. (Director · Since at least Oct 2, 2017); Momenta Pharmaceuticals Inc (Director · Jun 20, 2018 – Oct 1, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · May 29, 2018 – Dec 12, 2018 · Past) | Director · May 2, 2018 – Oct 16, 2024 · Past |
| Timothy M Mayleben Other companies: Landos Biopharma Inc (Director · May 13, 2021 – May 23, 2024 · Past); Loxo Oncology Inc (Director · Jul 28, 2015 – Feb 15, 2019 · Past); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Feb 7, 2025 · Past); Esperion Therapeutics, Inc. (President & CEO, Director · Jun 25, 2013 – Jan 28, 2021 · Past) | President and CEO, Director · Oct 17, 2008 – Aug 29, 2012 · Past |
| Kevin F. McLaughlin Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Decibel Therapeutics Inc (Director · Oct 10, 2022 – Sep 25, 2023 · Past); Acceleron Pharma Inc (SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past) | Director · Since at least Jan 6, 2015 |
| Paul Wotton Other companies: Ocata Therapeutics Inc (President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past); Antares Pharma Inc (President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past) | Director · Since at least Jan 6, 2015 |
| Heidi Hagen Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026); Alaunos Therapeutics, Inc. (Director · Jun 13, 2019 – Sep 2, 2021 · Past) | Director · Since at least Aug 23, 2013 |
| Scott Durbin Other companies: Motus GI Holdings, Inc. (Director · Sep 6, 2023 – Mar 5, 2024 · Past); Viveve Medical, Inc. (Chief Executive Officer, Director · Jun 17, 2016 – Jan 3, 2023 · Past) | CFO · Jan 4, 2012 – Jan 4, 2012 · Past |
| Dominick Colangelo Other companies: Trevi Therapeutics, Inc. (Director · Since at least Jun 29, 2020) | President and Chief Executive Officer · Since at least Mar 6, 2013 |
| Jonathan Mark Hopper Other companies: Osiris Therapeutics Inc (Chief Medical Officer · Nov 24, 2014 – Apr 12, 2016 · Past) | Chief Medical Officer · Since at least Feb 11, 2020 |
| Sandra Pennell Other companies: Delcath Systems, Inc. (CHIEF FINANCIAL OFFICER · Since at least Jun 1, 2023) | VP and Corporate Controller · Sep 30, 2020 – Sep 30, 2020 · Past |
| Alan L. Rubino | Director · Since at least Apr 29, 2026 |
All 24 people
| Person | Seat |
|---|---|
| Brian Gibson | Vice President · Oct 13, 2011 – May 3, 2012 · Past |
| Gerald Brennan Jr | VP Admin. and Finance, CFO · Feb 16, 2006 – Nov 30, 2007 · Past |
| Jonathan Siegal | Principal Accounting Officer · Since at least Feb 16, 2022 |
| Joseph A. Mara | Chief Financial Officer · Since at least Jun 30, 2026 |
| Joseph Anthony Mara Jr | Chief Financial Officer · Since at least May 7, 2026 |
| Karen Mahoney | Chief Human Resources Officer · Since at least Feb 19, 2025 |
| Lisa Wright | Director · Since at least Jun 1, 2021 |
| Michael Halpin | Chief Operating Officer · Since at least Jun 15, 2019 |
| Nelson M Sims | Director · Oct 17, 2008 – Mar 20, 2015 · Past |
| Robert Bard | VP Reg-Clinic Affairs &, QS. · Sep 7, 2006 – Sep 7, 2006 · Past |
| Robert L. Zerbe | Director · Since at least Apr 29, 2026 |
| Ronnda Bartel | Chief Scientific Officer · Oct 16, 2006 – Jun 25, 2012 · Past |
| Sean C Flynn | Chief Legal Officer · Since at least Jun 18, 2026 |
| Susan Wyant | Director · Nov 2, 2006 – Nov 7, 2007 · Past |
Log in to ask 6ix AI your own questions about Vericel Corporation.